In the fetus with a CCAM, the presence of hydrops fetalis or a CVR >1.6 is indicative of poor fetal outcome without prenatal intervention. The observed effect of antenatal steroid treatment on CCAM growth is variable, but its potential to improve survival in these high-risk groups is encouraging and warrants further controlled evaluations.
No takes yet. Share an insight, caveat, or question.
Peranteau et al. (2007) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: